Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma

被引:105
作者
Arif, S
Blanes, A
Diaz-Cano, SJ
机构
[1] Barts & London NHS Trust, Dept Histopathol, London, England
[2] Univ Hosp, Malaga, Spain
[3] Barts & London Sch Med Dent, London, England
关键词
papillary thyroid carcinoma; Hashimoto's thyroiditis; RET/PTC rearrangement; diagnostic criteria; molecular diagnosis;
D O I
10.1046/j.1365-2559.2002.01467.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neoplastic transformation is a multistep process that results in a continuous spectrum from the normal (physiological) state to a fully established neoplasm. The gold standard for diagnosis of papillary thyroid carcinoma is conventional histology, the essential element being the characteristic nuclear features, regardless of whether papillary structures are present or not. However, other criteria are being used increasingly in the diagnosis of neoplasms, including immunohistochemical staining and molecular profile. The RET/PTC gene rearrangement is highly specific for papillary thyroid carcinoma and is associated with the characteristic nuclear features seen in papillary thyroid carcinoma. There is an overlap in the morphological features, immunohistochemical staining pattern, and most importantly, molecular profile between papillary thyroid carcinoma and Hashimoto's thyroiditis. Although considered a 'benign' condition, Hashimoto's thyroiditis almost always harbours a genetic rearrangement that is strongly associated with and is highly specific for papillary thyroid carcinoma. Submicroscopic foci of papillary thyroid carcinoma must be present in Hashimoto's thyroiditis, although the clinical behaviour is still benign. Further studies are required to predict which foci will progress to papillary thyroid carcinoma.
引用
收藏
页码:357 / 362
页数:6
相关论文
共 32 条
[1]  
[Anonymous], 1992, ATLAS TUMOR PATHOL
[2]   Differential expression of cytokeratins in follicular variant of papillary carcinoma: An immunohistochemical study and its diagnostic utility [J].
Baloch, ZW ;
Abraham, S ;
Roberts, S ;
LiVolsi, VA .
HUMAN PATHOLOGY, 1999, 30 (10) :1166-1171
[3]   RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma [J].
Basolo, F ;
Molinaro, E ;
Agate, L ;
Pinchera, A ;
Pollina, L ;
Chiappetta, G ;
Monaco, C ;
Santoro, M ;
Fusco, A ;
Miccoli, P ;
Elisei, R ;
Capezzone, M ;
Pacini, F .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (05) :599-604
[4]   The 'dark nucleus' and disruptions of follicular architecture: possible new histological aids for the diagnosis of the follicular variant of papillary carcinoma of the thyroid [J].
Bell, CD ;
Coire, C ;
Treger, T ;
Volpe, R ;
Baumal, R ;
Fornasier, VL .
HISTOPATHOLOGY, 2001, 39 (01) :33-42
[5]  
BERHO M, 1995, ANN CLIN LAB SCI, V25, P513
[6]   High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation [J].
Bounacer, A ;
Wicker, R ;
Caillou, B ;
Cailleux, AF ;
Sarasin, A ;
Schlumberger, M ;
Suarez, HG .
ONCOGENE, 1997, 15 (11) :1263-1273
[7]   Molecular basis of Hurthle cell papillary thyroid carcinoma [J].
Cheung, CC ;
Ezzat, S ;
Ramyar, L ;
Freeman, JL ;
Asa, SL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :878-882
[8]   Immunohistochemical diagnosis of papillary thyroid carcinoma [J].
Cheung, CC ;
Ezzat, S ;
Freeman, JL ;
Rosen, IB ;
Asa, SL .
MODERN PATHOLOGY, 2001, 14 (04) :338-342
[9]   Pathologic features of Hashimoto's-associated papillary thyroid carcinomas [J].
Di Pasquale, M ;
Rothstein, JL ;
Palazzo, JP .
HUMAN PATHOLOGY, 2001, 32 (01) :24-30
[10]   The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults [J].
Fenton, CL ;
Lukes, Y ;
Nicholson, D ;
Dinauer, CA ;
Francis, GL ;
Tuttle, RM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1170-1175